When chronic joint pain, tendon injuries, or degenerative musculoskeletal conditions begin limiting your quality of life, you may benefit from advanced regenerative medicine therapies. At TOPS Institute, we offer comprehensive evaluations to determine whether autologous bone marrow-based regenerative therapy, often referred to as stem cell therapy, may be an appropriate treatment option for carefully selected patients.
Our board-certified interventional pain management specialists utilize advanced image-guided techniques to precisely deliver treatment while developing personalized care plans based on your diagnosis, medical history, and treatment goals.
Because regenerative medicine continues to evolve, our physicians emphasize evidence-based recommendations and discuss the potential benefits, limitations, risks, and available alternatives before treatment.
In orthopedic and pain management practice, what is commonly referred to as stem cell therapy often involves an autologous bone marrow-based procedure, meaning cells are obtained from your own body—typically bone marrow—and processed into a concentrated cellular product, such as Bone Marrow Aspirate Concentrate (BMAC).
The goal of these procedures is to deliver a concentrated biologic product to areas of tissue injury or degeneration in an effort to support the body’s natural healing response.
Unlike medications that primarily manage symptoms, regenerative medicine aims to create an environment that may support tissue repair. However, outcomes vary significantly depending on the condition being treated, the severity of tissue damage, and individual patient factors.
It is important to understand that regenerative medicine is an evolving field, and not every condition responds the same way.
Not every treatment marketed as “stem cell therapy” is the same.
Cell-based therapies may involve:
The type of product used, how it is processed, and the intended use can differ considerably.
Our physicians carefully review every treatment recommendation with patients so they understand exactly what is being offered, the current evidence supporting its use, and the available alternatives.
Depending on your diagnosis, regenerative medicine may be considered for selected patients with:
Not every patient is an appropriate candidate, and treatment recommendations are based on a thorough medical evaluation.
When appropriate, treatment generally involves several steps.
Your physician performs a detailed assessment that includes:
This evaluation helps determine whether regenerative medicine may be appropriate.
For autologous bone marrow-based procedures, bone marrow is typically collected from the patient’s own body under sterile conditions.
The collected tissue is processed to produce a concentrated cellular product.
The specific processing method depends on the procedure being performed.
Using ultrasound or fluoroscopic guidance, your physician precisely injects the concentrated cellular product into the targeted joint, tendon, ligament, or other treatment area when clinically appropriate.
Image guidance helps improve procedural accuracy.
Regenerative therapies are designed to support the body’s natural healing mechanisms rather than simply masking pain symptoms.
Because healing occurs gradually, improvement—when it occurs—is typically evaluated over weeks to months.
Most regenerative procedures are performed using injections without major surgery, allowing patients to return home the same day.
Every regenerative treatment plan is customized according to the patient’s diagnosis, imaging findings, symptoms, activity level, and long-term goals.
Depending on the condition being treated, some patients may experience:
Individual results vary, and improvement cannot be guaranteed.
Our physicians specialize in interventional pain management and regenerative medicine for musculoskeletal conditions.
Ultrasound and fluoroscopic imaging are used when clinically appropriate to improve treatment precision.
We emphasize careful patient selection and discuss the current scientific evidence, expected outcomes, limitations, and alternative treatment options before recommending regenerative procedures.
No two patients have the same condition.
Treatment recommendations are tailored to your diagnosis, severity of disease, medical history, and personal goals.
Although autologous bone marrow-based procedures are generally considered well tolerated when performed appropriately, every medical procedure carries potential risks.
Potential risks include:
Our physicians carefully review these risks and answer any questions before treatment.
In orthopedic and pain management practice, what is commonly called stem cell therapy often refers to an autologous bone marrow-based regenerative procedure that uses your own tissue to create a concentrated cellular product intended to support the body’s healing response.
Many regenerative cell-based therapies marketed for orthopedic and pain conditions are not FDA-approved for those specific uses. Patients should understand the type of treatment being offered, its tissue source, current evidence, and regulatory status before proceeding.
These procedures may be considered for selected patients with osteoarthritis, tendon injuries, ligament injuries, sports injuries, and certain degenerative musculoskeletal conditions. Candidacy depends on the diagnosis and overall clinical evaluation.
Autologous bone marrow-based procedures may be considered for certain patients with chronic back pain or degenerative spine conditions, but evidence remains mixed and depends on the specific diagnosis. These treatments should not be viewed as a proven cure for chronic back pain.
Research continues to evolve. Some patients report improvements in pain and function, while others experience limited or no benefit. Results vary considerably depending on the condition being treated and individual patient factors.
Autologous procedures use your own tissue, which generally reduces the risk of immune rejection. However, risks still include infection, bleeding, pain at the collection site, nerve injury, failure to improve, and other procedure-related complications.
Because regenerative therapies rely on the body’s natural healing response, improvement—when it occurs—is generally gradual and may take several weeks to several months.
Not necessarily. Some patients experience meaningful improvement, while others may have temporary or limited benefit. Long-term outcomes vary based on the condition being treated and individual response.
The best way to determine candidacy is through a comprehensive consultation. Our physicians evaluate your diagnosis, imaging studies, previous treatments, and overall health before recommending regenerative therapy.
Both are regenerative medicine treatments but differ in the biologic material used. PRP (Platelet-Rich Plasma) uses concentrated platelets from your blood, while autologous bone marrow-based procedures use cellular material obtained from your bone marrow. Your physician will determine which option, if any, is most appropriate for your condition.
If chronic joint pain, arthritis, tendon injuries, or sports-related conditions are affecting your quality of life, regenerative medicine may be one of several treatment options worth exploring.
At TOPS Institute, our experienced physicians provide comprehensive evaluations and personalized treatment plans to determine whether autologous bone marrow-based regenerative therapy, commonly referred to as stem cell therapy, is appropriate for your specific condition.
Contact us today to schedule your consultation and learn more about your regenerative medicine treatment options.
Leave a message or give us a call — we'll find a time that works for you.
640 South San Vicente Blvd., Suite 389, Los Angeles, CA 90048
Interventional pain management for Los Angeles & Beverly Hills — image-guided care that treats the source, not just the symptom.
© 2026 TOPS Institute · All rights reserved · Home
